Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
  1. 4 Planned sale Chief Financial Officer sold 610 shares at $2.64 ($1,610)
  2. 4 Planned sale Chief Financial Officer sold 562 shares at $2.89 ($1,624)
  3. 4 Planned sale Chief Financial Officer sold 840 shares at $1.84 ($1,545)
  4. 4 Open-market sale Chief Financial Officer sold 892 shares at $1.75 ($1,564)
  5. 4 Exercise or conversion Chief Commercial Officer acquired 18,750 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Chief Financial Officer sold 8,474 shares at $2.45 ($20,761)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Former 10% Owner sold 500,000 shares at an average $2.89 ($1,444,012)
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4/A Derivatives Options or other derivatives

Page 5 of 13 · 257 filings